PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29377229-0	2018	microRNA-129-5p involved in the neuroprotective effect of dexmedetomidine on hypoxic-ischemic brain injury by targeting COL3A1 through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	58-73	collagen type III alpha 1 chain	Rattus norvegicus	120-126	
29377229-0	2018	microRNA-129-5p involved in the neuroprotective effect of dexmedetomidine on hypoxic-ischemic brain injury by targeting COL3A1 through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	58-73	catenin beta 1	Rattus norvegicus	143-155	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	118-133	microRNA 1295a	Homo sapiens	64-74	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	118-133	collagen type III alpha 1 chain	Rattus norvegicus	224-230	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	118-133	catenin beta 1	Rattus norvegicus	248-260	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	135-138	microRNA 1295a	Homo sapiens	64-74	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	135-138	collagen type III alpha 1 chain	Rattus norvegicus	224-230	
29377229-1	2018	Our study aims to elucidate the mechanisms how microRNA-129-5p (miR-129-5p) involved in the neuroprotective effect of dexmedetomidine (DEX) on hypoxic-ischemic brain injury (HIBI) by targeting the type III procollagen gene (COL3A1) through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	135-138	catenin beta 1	Rattus norvegicus	248-260	
29377229-9	2018	Our findings demonstrate that miR-129-5p improves the neuroprotective role of DEX in HIBI by targeting COL3A1 through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	78-81	microRNA 1295a	Homo sapiens	30-40	
29377229-9	2018	Our findings demonstrate that miR-129-5p improves the neuroprotective role of DEX in HIBI by targeting COL3A1 through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	78-81	collagen type III alpha 1 chain	Rattus norvegicus	103-109	
29377229-9	2018	Our findings demonstrate that miR-129-5p improves the neuroprotective role of DEX in HIBI by targeting COL3A1 through the Wnt/beta-catenin signaling pathway in neonatal rats.	Dexmedetomidine	78-81	catenin beta 1	Rattus norvegicus	126-138